Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In an introductory tutorial, we illustrated building cohort state-transition models (cSTMs) in R, where the state transition probabilities were constant over time. However, in practice, many cSTMs require transitions, rewards, or both to vary over time (time dependent). This tutorial illustrates adding 2 types of time dependence using a previously published cost-effectiveness analysis of multiple strategies as an example. The first is simulation-time dependence, which allows for the transition probabilities to vary as a function of time as measured since the start of the simulation (e.g., varying probability of death as the cohort ages). The second is state-residence time dependence, allowing for history by tracking the time spent in any particular health state using tunnel states. We use these time-dependent cSTMs to conduct cost-effectiveness and probabilistic sensitivity analyses. We also obtain various epidemiological outcomes of interest from the outputs generated from the cSTM, such as survival probability and disease prevalence, often used for model calibration and validation. We present the mathematical notation first, followed by the R code to execute the calculations. The full R code is provided in a public code repository for broader implementation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844995PMC
http://dx.doi.org/10.1177/0272989X221121747DOI Listing

Publication Analysis

Top Keywords

cohort state-transition
8
state-transition models
8
cost-effectiveness analysis
8
transition probabilities
8
time dependence
8
time
7
tutorial time-dependent
4
time-dependent cohort
4
models cost-effectiveness
4
analysis example
4

Similar Publications

Health-economic evaluation of an AI-powered decision support system for anemia management in in-center hemodialysis patients.

BMC Nephrol

August 2025

Market Access, Health Economics & Political Affairs, Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.

Background: The Anemia Control Model (ACM) is a decision support system powered by an artificial intelligence core designed to assist nephrologists in managing anemia therapy for in-center hemodialysis (HD) patients. This study aims to evaluate the cost-effectiveness of the ACM compared to standard of care in Germany, defined as the absence of ACM and a hemoglobin (Hb) target achievement rate of less than 70% among in-center HD patients, based on results from matched observational studies.

Methods: This simulation study adopted the perspective of the German statutory health insurance.

View Article and Find Full Text PDF

Objective: This study aims to explore individual- and country-level factors associated with loneliness' transitions and estimate total life expectancy (TLE) and lonely life expectancy (LLE) at age 60 across 24 countries.

Design: This is a longitudinal study.

Setting: Data were drawn from five harmonized multinational cohorts.

View Article and Find Full Text PDF

Background: Chronic hepatitis B (CHB) remains a significant health burden for at least a hundred thousand Canadians. The government of Canada has endorsed the global strategy to eliminate hepatitis as a public health threat by 2030, but effectively targeting public health interventions is complicated by the silent nature of the disease, which can remain asymptomatic for decades.

Objective: This study develops a framework to estimate the prevalence of CHB and the proportion of the infected population that remains undiagnosed.

View Article and Find Full Text PDF

Objectives: Obesity is a leading risk factor for global morbidity and mortality, associated with significant healthcare costs that exceed US$260 billion annually in the USA. Weight cycling, the repeated pattern of intentional weight loss followed by unintentional regain, can exacerbate obesity-related health complications. This study aimed to assess the health economic consequences of weight cycling in patients with obesity defined by a body mass index (BMI) ≥30 kg/m², comparing 'weight cyclers' with 'non-cyclers', and evaluating the impact of a high-protein oral nutritional supplement (HP-ONS) as a maintenance strategy following weight loss via glucagon-like peptide-1 receptor agonists (GLP-1RAs).

View Article and Find Full Text PDF

Proteinuria, a critical marker of glomerulosclerosis, poses a challenge in idiopathic membranous nephropathy (iMN), particularly when standard treatments fail. Acthar® Gel, a US Food and Drug Administration-approved treatment option, may offer an alternative for managing refractory proteinuria in nephrotic syndrome (NS) due to iMN where multiple treatments have failed. The cost per response of Acthar® Gel vs standard of care (SoC; cyclophosphamide or rituximab) for treatment of proteinuria in NS due to iMN was evaluated among adults who had failed multiple treatments from a US payer perspective over a 1- to 3-year horizon.

View Article and Find Full Text PDF